Riskpilot← Back to searchSign inGet full accessL.Pharma AB
ABBankruptOrg 5591238265Business and other management consultancy activities · NACE 7020Est. 20170 employees
Revenue 2022
SEK 13,1M
+8% vs 2021
EBITDA margin
3.9%
-47% vs 2021
Equity ratio
18.2%
Financial strength
Net profit 2022
SEK 304K
-57% vs 2021
| Revenue | SEK 13,1M | +8% |
| EBITDA | SEK 518K | -47% |
| Net profit | SEK 304K | -57% |
| Total assets | SEK 7,5M | +65% |
| Equity | SEK 1,4M | +77% |
| Employees | 0 | — |
Legal name
L.Pharma AB
Org number
5591238265
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
4 september 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall driva konsultverksamhet och service mot GxP- klassad och medicinsk utrustning.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenue | — | 4 149 | 6 266 | 6 445 | 12 127 | 13 134 |
| Staff expenses | — | — | — | — | — | −7 552 |
| EBITDA | 220 | 329 | −3 809 | −3 612 | 982 | 518 |
| Depreciation & amort. | −0 | −6 | −17 | −24 | −33 | −63 |
| EBIT | 220 | 323 | −3 826 | −3 636 | 949 | 455 |
| Net financials | — | −8 | −93 | −504 | −241 | −151 |
| Profit before tax | 220 | 216 | −3 819 | −4 140 | 709 | 304 |
| Tax | −52 | −69 | −0 | −0 | −0 | — |
| Net profit | 168 | 147 | −3 819 | −4 140 | 709 | 304 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Total assets | 394 | 1 188 | 4 708 | 4 888 | 4 529 | 7 453 |
| Equity | 218 | 265 | −376 | 51 | 766 | 1 359 |
| Long-term debt | 0 | 25 | 899 | 953 | 350 | 1 156 |
| Short-term debt | 176 | 798 | 4 185 | 3 884 | 3 413 | 4 937 |
| Total debt | 176 | 823 | 5 084 | 4 837 | 3 763 | 6 093 |
EBITDA margin
3.9%
This company
15.8%
Market median
-75% vs market
20172022
Equity ratio
18.2%
This company
38.2%
Market median
-52% vs market
20172022
Return on equity
22.3%
This company
18.4%
Market median
+21% vs market
20172022
Net profit margin
2.3%
This company
8.1%
Market median
-72% vs market
20172022
Asset turnover
1.76×
This company
1.12×
Market median
+57% vs market
20172022
Debt / equity
4.48×
This company
0.62×
Market median
-623% vs market
20172022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-09-01 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LT Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Sonima Group AB | Company | 75.0% | 75.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sonima Group AB
L.Pharma AB Board members of L.Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Tore Ekberg | Chief Executive Officer | 0 companies |
| Sofie Eva Terese Wirandi | Board of Directors | 0 companies |
| Nils Olof Karlsson | Board of Directors | 0 companies |
| Ann-Catrine Viktoria Ekberg | Deputy Board Member | 0 companies |
| Anders Mattias Liss | Chairman | 0 companies |
| Tommy Per Erik Nilsson | Chairman | 0 companies |